138 related articles for article (PubMed ID: 34019298)
1. Generation of a Tetracycline Regulated Mouse Model of MYC-Induced T-Cell Acute Lymphoblastic Leukemia.
Mahauad-Fernandez WD; Rakhra K; Felsher DW
Methods Mol Biol; 2021; 2318():297-312. PubMed ID: 34019298
[TBL] [Abstract][Full Text] [Related]
2. Generation of a tetracycline regulated mouse model of MYC-induced T-cell acute lymphoblastic leukemia.
Rakhra K; Felsher DW
Methods Mol Biol; 2013; 1012():221-35. PubMed ID: 24006068
[TBL] [Abstract][Full Text] [Related]
3. Molecularly distinct models of zebrafish Myc-induced B cell leukemia.
Borga C; Foster CA; Iyer S; Garcia SP; Langenau DM; Frazer JK
Leukemia; 2019 Feb; 33(2):559-562. PubMed ID: 30573774
[No Abstract] [Full Text] [Related]
4. RUNX1 is required for oncogenic
Choi A; Illendula A; Pulikkan JA; Roderick JE; Tesell J; Yu J; Hermance N; Zhu LJ; Castilla LH; Bushweller JH; Kelliher MA
Blood; 2017 Oct; 130(15):1722-1733. PubMed ID: 28790107
[TBL] [Abstract][Full Text] [Related]
5. MYC fails to efficiently shape malignant transformation in T-cell acute lymphoblastic leukemia.
Loosveld M; Bonnet M; Gon S; Montpellier B; Quilichini B; Navarro JM; Crouzet T; Goujart MA; Chasson L; Morgado E; Picard C; Hernandez L; Fossat C; Gabert J; Michel G; Nadel B; Payet-Bornet D
Genes Chromosomes Cancer; 2014 Jan; 53(1):52-66. PubMed ID: 24249258
[TBL] [Abstract][Full Text] [Related]
6. The NOTCH1-MYC highway toward T-cell acute lymphoblastic leukemia.
Sanchez-Martin M; Ferrando A
Blood; 2017 Mar; 129(9):1124-1133. PubMed ID: 28115368
[TBL] [Abstract][Full Text] [Related]
7. Pten mediates Myc oncogene dependence in a conditional zebrafish model of T cell acute lymphoblastic leukemia.
Gutierrez A; Grebliunaite R; Feng H; Kozakewich E; Zhu S; Guo F; Payne E; Mansour M; Dahlberg SE; Neuberg DS; den Hertog J; Prochownik EV; Testa JR; Harris M; Kanki JP; Look AT
J Exp Med; 2011 Aug; 208(8):1595-603. PubMed ID: 21727187
[TBL] [Abstract][Full Text] [Related]
8. A NOTCH1-driven MYC enhancer promotes T cell development, transformation and acute lymphoblastic leukemia.
Herranz D; Ambesi-Impiombato A; Palomero T; Schnell SA; Belver L; Wendorff AA; Xu L; Castillo-Martin M; Llobet-Navás D; Cordon-Cardo C; Clappier E; Soulier J; Ferrando AA
Nat Med; 2014 Oct; 20(10):1130-7. PubMed ID: 25194570
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous B and T cell acute lymphoblastic leukemias in zebrafish driven by transgenic MYC: implications for oncogenesis and lymphopoiesis.
Borga C; Park G; Foster C; Burroughs-Garcia J; Marchesin M; Shah R; Hasan A; Ahmed ST; Bresolin S; Batchelor L; Scordino T; Miles RR; Te Kronnie G; Regens JL; Frazer JK
Leukemia; 2019 Feb; 33(2):333-347. PubMed ID: 30111845
[TBL] [Abstract][Full Text] [Related]
10. Loss of function tp53 mutations do not accelerate the onset of myc-induced T-cell acute lymphoblastic leukaemia in the zebrafish.
Gutierrez A; Feng H; Stevenson K; Neuberg DS; Calzada O; Zhou Y; Langenau DM; Look AT
Br J Haematol; 2014 Jul; 166(1):84-90. PubMed ID: 24690081
[TBL] [Abstract][Full Text] [Related]
11. BIM mediates oncogene inactivation-induced apoptosis in multiple transgenic mouse models of acute lymphoblastic leukemia.
Li Y; Deutzmann A; Choi PS; Fan AC; Felsher DW
Oncotarget; 2016 May; 7(19):26926-34. PubMed ID: 27095570
[TBL] [Abstract][Full Text] [Related]
12. T-ALL pathogenesis requires a NOTCH1-driven MYC enhancer.
Cancer Discov; 2014 Nov; 4(11):OF17. PubMed ID: 25367958
[TBL] [Abstract][Full Text] [Related]
13. Co-targeting of Akt and Myc inhibits viability of lymphoma cells from Lck-Dlx5 mice.
Tan Y; Sementino E; Pei J; Kadariya Y; Ito TK; Testa JR
Cancer Biol Ther; 2015; 16(4):580-8. PubMed ID: 25793663
[TBL] [Abstract][Full Text] [Related]
14. Lymphomas that recur after MYC suppression continue to exhibit oncogene addiction.
Choi PS; van Riggelen J; Gentles AJ; Bachireddy P; Rakhra K; Adam SJ; Plevritis SK; Felsher DW
Proc Natl Acad Sci U S A; 2011 Oct; 108(42):17432-7. PubMed ID: 21969595
[TBL] [Abstract][Full Text] [Related]
15. Clonal evolution enhances leukemia-propagating cell frequency in T cell acute lymphoblastic leukemia through Akt/mTORC1 pathway activation.
Blackburn JS; Liu S; Wilder JL; Dobrinski KP; Lobbardi R; Moore FE; Martinez SA; Chen EY; Lee C; Langenau DM
Cancer Cell; 2014 Mar; 25(3):366-78. PubMed ID: 24613413
[TBL] [Abstract][Full Text] [Related]
16. Oncogenesis of T-ALL and nonmalignant consequences of overexpressing intracellular NOTCH1.
Li X; Gounari F; Protopopov A; Khazaie K; von Boehmer H
J Exp Med; 2008 Nov; 205(12):2851-61. PubMed ID: 18981238
[TBL] [Abstract][Full Text] [Related]
17. Oncogenic cooperation between TCF7-SPI1 and NRAS(G12D) requires β-catenin activity to drive T-cell acute lymphoblastic leukemia.
Van Thillo Q; De Bie J; Seneviratne JA; Demeyer S; Omari S; Balachandran A; Zhai V; Tam WL; Sweron B; Geerdens E; Gielen O; Provost S; Segers H; Boeckx N; Marshall GM; Cheung BB; Isobe K; Kato I; Takita J; Amos TG; Deveson IW; McCalmont H; Lock RB; Oxley EP; Garwood MM; Dickins RA; Uyttebroeck A; Carter DR; Cools J; de Bock CE
Nat Commun; 2021 Jul; 12(1):4164. PubMed ID: 34230493
[TBL] [Abstract][Full Text] [Related]
18. MYC Analysis in Cancer and Evolution.
Hartl M; Bister K
Methods Mol Biol; 2021; 2318():87-117. PubMed ID: 34019288
[TBL] [Abstract][Full Text] [Related]
19. MYC regulates the antitumor immune response through CD47 and PD-L1.
Casey SC; Tong L; Li Y; Do R; Walz S; Fitzgerald KN; Gouw AM; Baylot V; Gütgemann I; Eilers M; Felsher DW
Science; 2016 Apr; 352(6282):227-31. PubMed ID: 26966191
[TBL] [Abstract][Full Text] [Related]
20. JDP2: An oncogenic bZIP transcription factor in T cell acute lymphoblastic leukemia.
Mansour MR; He S; Li Z; Lobbardi R; Abraham BJ; Hug C; Rahman S; Leon TE; Kuang YY; Zimmerman MW; Blonquist T; Gjini E; Gutierrez A; Tang Q; Garcia-Perez L; Pike-Overzet K; Anders L; Berezovskaya A; Zhou Y; Zon LI; Neuberg D; Fielding AK; Staal FJT; Langenau DM; Sanda T; Young RA; Look AT
J Exp Med; 2018 Jul; 215(7):1929-1945. PubMed ID: 29941549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]